Economic evaluation of olmesartan/amlodipine fixed-dose combination for hypertension treatment in China-Reference-Cited by-同舟云学术

Economic evaluation of olmesartan/amlodipine fixed-dose combination for hypertension treatment in China

Published:2020-01-25 Issue:4 Volume:23 Page:394-400
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Ren Maodong¹,Xuan Dennis²,Lu Yongji¹,Fu YuYan³,Xuan Jianwei³

Affiliation:

1. Shanghai Centennial Scientific Co., Ltd, Shanghai, China;

2. Gillings Global School of Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, USA;

3. Health Economic Research Institute, Sun Yat-Sen University, Guangzhou, China

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2019.1699799

Reference32 articles.

1. Efficacy and safety of a single-pill combination of amlodipine/valsartan in Asian hypertensive patients inadequately controlled with amlodipine monotherapy

2. NHFPC. China's health and family planning statistical yearbook 2017. National Health and Family Planning Commission of the People's Republic of China.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Economic Evaluation of Fixed-dose Drug Combinations: A Systematic Review;2024-06-06

2. Management of Hypertension in the Asia-Pacific Region: A Structured Review;American Journal of Cardiovascular Drugs;2024-02-08

3. Effectiveness of Single-Tablet Combination Therapy in Improving Adherence and Persistence and the Relation to Clinical and Economic Outcomes;Journal of Health Economics and Outcomes Research;2024-01-23

4. Effectiveness of Single-Tablet Combination Therapy in Improving Adherence and Persistence and the Relation to Clinical and Economic Outcomes;Journal of Health Economics and Outcomes Research;2024

5. Efficacy and safety of olmesartan medoxomil‐amlodipine besylate tablet in Chinese patients with essential hypertension: A prospective, single‐arm, multi‐center, real‐world study;The Journal of Clinical Hypertension;2023-09-04